Cleared Traditional

K900206 - LYME DISEASE IGM ELISA

K900206 is an FDA 510(k) clearance for LYME DISEASE IGM ELISA, manufactured by Hillcrest Biologicals. The device is a Class 2 Microbiology device with product code LSR cleared through the Traditional 510(k) pathway after a 528-day FDA review.

K900206 · Hillcrest Biologicals · Microbiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 1991
Decision
528d
Days
Class 2
Risk

K900206 is an FDA 510(k) clearance for the LYME DISEASE IGM ELISA. Classified as Reagent, Borrelia Serological Reagent (product code LSR), Class II - Special Controls.

Submitted by Hillcrest Biologicals (Cypress, US). The FDA issued a Cleared decision on June 28, 1991 after a review of 528 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.3830 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Microbiology submissions.

View all Hillcrest Biologicals devices

FDA 510(k) Submission Details - K900206

510(k) Number K900206 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 16, 1990
Decision Date June 28, 1991
Days to Decision 528 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
426d slower than avg
Panel avg: 102d · This submission: 528d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LSR Device Classification - Class 2, Special Controls

Product Code LSR Reagent, Borrelia Serological Reagent
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.3830
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Microbiology devices follow this clearance model.

Regulatory Peers - LSR Reagent, Borrelia Serological Reagent

All 97
Devices cleared under the same product code (LSR) and FDA review panel - the closest regulatory comparables to K900206.
LYME STAT M TEST KIT
K904652 · Whittaker Bioproducts, Inc. · Oct 1991
FIAX LYME M TEST KIT
K904893 · Whittaker Bioproducts, Inc. · Oct 1991
LYME-SPOT IF KIT
K910230 · Vitek Systems, Inc. · Aug 1991
LYME IGM ELISA TEST
K903013 · Gull Laboratories, Inc. · Jun 1991
LYME DISEASE MICROASSAY
K910899 · Diamedix Corp. · Jun 1991
LYME IGM MICROASSAY
K911330 · Diamedix Corp. · Jun 1991